AGIOS PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 851.78 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-07-30
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 134.55K shares, a 16.80% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 717.23K shares, a 0.84% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 22.91K shares, a 14.05% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 63.53K shares, a 0.93% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 971.46K shares, a 7.49% decline from fiscal 2024.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.05M shares, a 18.41% increase from fiscal 2023.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 886.79K shares, a 52.07% decline from fiscal 2022.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.85M shares, a 72.26% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 134.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | 851.78K shares 10-Q · filed 2026-07-30 | 874.69K shares derived: sum of 3 quarters · filed 2026-07-30 | 938.21K shares derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | 717.23K shares 10-Q · filed 2026-04-29 | 740.14K shares derived: sum of 2 quarters · filed 2026-04-29 | 803.66K shares derived: sum of 3 quarters · filed 2026-04-29 | 965.37K shares derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | 22.91K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 86.44K shares derived: sum of 2 quarters · filed 2026-02-12 | 248.15K shares derived: sum of 3 quarters · filed 2026-02-12 | 971.46K shares 10-K · filed 2026-02-12 |
| 2025-09-30 | 63.53K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | 225.24K shares derived: sum of 2 quarters · filed 2025-10-30 | 948.55K shares 10-Q · filed 2025-10-30 | 975.21K shares derived: sum of 4 quarters · filed 2025-10-30 |
| 2025-06-30 | 161.71K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | 885.02K shares 10-Q · filed 2025-07-31 | 911.68K shares derived: sum of 3 quarters · filed 2025-07-31 | 974.62K shares derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | 723.31K shares 10-Q · filed 2025-05-01 | 749.97K shares derived: sum of 2 quarters · filed 2025-05-01 | 812.91K shares derived: sum of 3 quarters · filed 2025-05-01 | 964.99K shares derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-12-31 | 26.65K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | 89.60K shares derived: sum of 2 quarters · filed 2025-02-13 | 241.67K shares derived: sum of 3 quarters · filed 2025-02-13 | 1.05M shares 10-K · filed 2025-02-13 |
| 2024-09-30 | 62.95K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | 215.02K shares derived: sum of 2 quarters · filed 2024-10-31 | 1.02M shares 10-Q · filed 2024-10-31 | 1.04M shares derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-06-30 | 152.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 960.49K shares 10-Q · filed 2024-08-01 | 976.36K shares derived: sum of 3 quarters · filed 2024-08-01 | 993.60K shares derived: sum of 4 quarters · filed 2024-08-01 |
| 2024-03-31 | 808.41K shares 10-Q · filed 2024-05-02 | 824.29K shares derived: sum of 2 quarters · filed 2024-05-02 | 841.52K shares derived: sum of 3 quarters · filed 2024-05-02 | 1.06M shares derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | 15.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | 33.11K shares derived: sum of 2 quarters · filed 2024-02-15 | 255.12K shares derived: sum of 3 quarters · filed 2024-02-15 | 886.79K shares 10-K · filed 2024-02-15 |
| 2023-09-30 | 17.24K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 239.25K shares derived: sum of 2 quarters · filed 2023-11-02 | 870.92K shares 10-Q · filed 2023-11-02 | 891.04K shares derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-06-30 | 222.01K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 853.69K shares 10-Q · filed 2023-08-03 | 873.81K shares derived: sum of 3 quarters · filed 2023-08-03 | 1.66M shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 631.68K shares 10-Q · filed 2023-05-04 | 651.80K shares derived: sum of 2 quarters · filed 2023-05-04 | 1.44M shares derived: sum of 3 quarters · filed 2023-05-04 | 1.83M shares derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | 20.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 806.67K shares derived: sum of 2 quarters · filed 2023-02-23 | 1.20M shares derived: sum of 3 quarters · filed 2023-02-23 | 1.85M shares 10-K · filed 2023-02-23 |
| 2022-09-30 | 786.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 1.18M shares derived: sum of 2 quarters · filed 2022-11-03 | 1.83M shares 10-Q · filed 2022-11-03 | 1.87M shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 395.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 1.04M shares 10-Q · filed 2022-08-04 | 1.08M shares derived: sum of 3 quarters · filed 2022-08-04 | 1.12M shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 647.71K shares 10-Q · filed 2022-05-05 | 685.26K shares derived: sum of 2 quarters · filed 2022-05-05 | 722.21K shares derived: sum of 3 quarters · filed 2022-05-05 | 849.03K shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 37.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 74.50K shares derived: sum of 2 quarters · filed 2022-02-24 | 201.32K shares derived: sum of 3 quarters · filed 2022-02-24 | 1.07M shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 36.95K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | 163.77K shares derived: sum of 2 quarters · filed 2021-11-03 | 1.04M shares 10-Q · filed 2021-11-03 | 1.08M shares derived: sum of 4 quarters · filed 2021-11-03 |
| 2021-06-30 | 126.82K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | 999.49K shares 10-Q · filed 2021-07-29 | 1.05M shares derived: sum of 3 quarters · filed 2021-07-29 | 1.08M shares derived: sum of 4 quarters · filed 2021-07-29 |
| 2021-03-31 | 872.67K shares 10-Q · filed 2021-04-29 | 919.87K shares derived: sum of 2 quarters · filed 2021-04-29 | 954.00K shares derived: sum of 3 quarters · filed 2021-04-29 | 1.08M shares derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-12-31 | 47.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 81.33K shares derived: sum of 2 quarters · filed 2021-02-25 | 212.10K shares derived: sum of 3 quarters · filed 2021-02-25 | 1.00M shares 10-K · filed 2021-02-25 |
| 2020-09-30 | 34.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 164.90K shares derived: sum of 2 quarters · filed 2020-11-05 | 956.95K shares 10-Q · filed 2020-11-05 | 1.15M shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 130.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | 922.82K shares 10-Q · filed 2020-07-30 | 1.12M shares derived: sum of 3 quarters · filed 2020-07-30 | 1.23M shares derived: sum of 4 quarters · filed 2020-07-30 |
| 2020-03-31 | 792.05K shares 10-Q · filed 2020-04-30 | 986.85K shares derived: sum of 2 quarters · filed 2020-04-30 | 1.10M shares derived: sum of 3 quarters · filed 2020-04-30 | 1.21M shares derived: sum of 4 quarters · filed 2020-04-30 |
| 2019-12-31 | 194.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | 307.76K shares derived: sum of 2 quarters · filed 2020-02-19 | 415.30K shares derived: sum of 3 quarters · filed 2020-02-19 | 1.77M shares 10-K · filed 2020-02-19 |
| 2019-09-30 | 112.96K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | 220.50K shares derived: sum of 2 quarters · filed 2019-10-31 | 1.58M shares 10-Q · filed 2019-10-31 | 1.63M shares derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | 107.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 1.46M shares 10-Q · filed 2019-08-01 | 1.52M shares derived: sum of 3 quarters · filed 2019-08-01 | 1.59M shares derived: sum of 4 quarters · filed 2019-08-01 |
| 2019-03-31 | 1.36M shares 10-Q · filed 2019-05-02 | 1.41M shares derived: sum of 2 quarters · filed 2019-05-02 | 1.48M shares derived: sum of 3 quarters · filed 2019-05-02 | 1.60M shares derived: sum of 4 quarters · filed 2019-05-02 |
| 2018-12-31 | 53.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | 122.08K shares derived: sum of 2 quarters · filed 2019-02-14 | 239.53K shares derived: sum of 3 quarters · filed 2019-02-14 | 1.35M shares 10-K · filed 2019-02-14 |
| 2018-09-30 | 68.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 185.80K shares derived: sum of 2 quarters · filed 2018-11-01 | 1.29M shares 10-Q · filed 2018-11-01 | 1.42M shares derived: sum of 4 quarters · filed 2018-11-01 |
| 2018-06-30 | 117.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 1.22M shares 10-Q · filed 2018-08-02 | 1.35M shares derived: sum of 3 quarters · filed 2018-08-02 | 1.49M shares derived: sum of 4 quarters · filed 2018-08-02 |
| 2018-03-31 | 1.11M shares 10-Q · filed 2018-05-04 | 1.23M shares derived: sum of 2 quarters · filed 2018-05-04 | 1.37M shares derived: sum of 3 quarters · filed 2018-05-04 | 1.60M shares derived: sum of 4 quarters · filed 2018-05-04 |
| 2017-12-31 | 126.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | 262.80K shares derived: sum of 2 quarters · filed 2018-02-14 | 491.30K shares derived: sum of 3 quarters · filed 2018-02-14 | 1.62M shares 10-K · filed 2018-02-14 |
| 2017-09-30 | 136.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | 364.90K shares derived: sum of 2 quarters · filed 2017-11-01 | 1.49M shares 10-Q · filed 2017-11-01 | 1.67M shares derived: sum of 4 quarters · filed 2017-11-01 |
| 2017-06-30 | 228.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 1.36M shares 10-Q · filed 2017-08-08 | 1.53M shares derived: sum of 3 quarters · filed 2017-08-08 | 1.76M shares derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | 1.13M shares 10-Q · filed 2017-05-04 | 1.30M shares derived: sum of 2 quarters · filed 2017-05-04 | 1.53M shares derived: sum of 3 quarters · filed 2017-05-04 | 1.75M shares derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-12-31 | 170.85K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | 400.30K shares derived: sum of 2 quarters · filed 2017-02-16 | 618.58K shares derived: sum of 3 quarters · filed 2017-02-16 | 1.56M shares 10-K · filed 2017-02-16 |
| 2016-09-30 | 229.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 447.73K shares derived: sum of 2 quarters · filed 2016-11-03 | 1.39M shares 10-Q · filed 2016-11-03 | 1.49M shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | 218.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | 1.16M shares 10-Q · filed 2016-08-08 | 1.26M shares derived: sum of 3 quarters · filed 2016-08-08 | 1.41M shares derived: sum of 4 quarters · filed 2016-08-08 |
| 2016-03-31 | 937.66K shares 10-Q · filed 2016-05-09 | 1.04M shares derived: sum of 2 quarters · filed 2016-05-09 | 1.19M shares derived: sum of 3 quarters · filed 2016-05-09 | 1.48M shares derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-12-31 | 100.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | 256.61K shares derived: sum of 2 quarters · filed 2016-02-26 | 538.60K shares derived: sum of 3 quarters · filed 2016-02-26 | 1.46M shares 10-K · filed 2016-02-26 |
| 2015-09-30 | 155.98K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | 437.96K shares derived: sum of 2 quarters · filed 2015-11-06 | 1.36M shares 10-Q · filed 2015-11-06 | 1.52M shares derived: sum of 4 quarters · filed 2015-11-06 |
| 2015-06-30 | 281.99K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | 1.20M shares 10-Q · filed 2015-08-07 | 1.37M shares derived: sum of 3 quarters · filed 2015-08-07 | 1.47M shares derived: sum of 4 quarters · filed 2015-08-07 |
| 2015-03-31 | 922.64K shares 10-Q · filed 2015-05-11 | 1.09M shares derived: sum of 2 quarters · filed 2015-05-11 | 1.19M shares derived: sum of 3 quarters · filed 2015-05-11 | 1.52M shares derived: sum of 4 quarters · filed 2015-05-11 |
| 2014-12-31 | 162.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | 266.67K shares derived: sum of 2 quarters · filed 2015-02-24 | 592.87K shares derived: sum of 3 quarters · filed 2015-02-24 | 1.34M shares 10-K · filed 2015-02-24 |
| 2014-09-30 | 103.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | 430.12K shares derived: sum of 2 quarters · filed 2014-11-07 | 1.18M shares 10-Q · filed 2014-11-07 | |
| 2014-06-30 | 326.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | 1.07M shares 10-Q · filed 2014-08-07 | ||
| 2014-03-31 | 746.61K shares 10-Q · filed 2014-05-09 | |||
| 2013-12-31 | 986.29K shares 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |